>
Organization
Ligand Pharmaceuticals, Inc.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed

News on Ligand Pharmaceuticals, Inc.

... Biopharma company Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) disclosed on Wednesday the launch of a worldwide OmniAb partnership ...
... Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announces it has entered into a worldwide OmniAb partnership with ...
... UK, which in turn is a wholly owned subsidiary of Ligand Pharmaceuticals Incorporated (NASDAQ: LGND). About Ligand Pharmaceuticals Ligand is a biopharmaceutical company focused on ...
... Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today reported financial results for the three and nine months ...
... Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announces that the company is scheduled to participate in Stephens ...
... Inc. (NASD: CA) in the S&P 500, S&P SmallCap 600 constituent Ligand Pharmaceuticals Inc. (NASD: LGND) will replace Keysight Technologies in the S&P MidCap 400, ...
... latest key findings for all current investors, traders, and shareholders of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND), AptarGroup, Inc. (NYSE:ATR), Unifirst Corporation (NYSE:UNF), Universal Corporation (NYSE:UVV), AutoZone, ...
... SAN DIEGO - Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced today plans to report third quarter 2018 financial results ...
... Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced today plans to report third quarter 2018 financial results ...
Subscribe now for full coverage on Ligand Pharmaceuticals, Inc.
Start My Free Trial